ATX-04 is a selective β2-adrenergic agonist with human proof-of-concept data demonstrating improved muscle function and enhanced response to ...

An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...

Please provide your email address to receive an email when new articles are posted on . Corticosteroid use during pregnancy was not linked with developmental milestone delays. Beta-2 adrenergic ...

The centrally acting alpha2-adrenergic agonist is approved for patients 6 years of age and older. HealthDay News — The US Food and Drug Administration has approved once-daily Onyda XR (clonidine ...